Genetic Testing Market Research Report By Application (Prenatal Testing, Newborn Screening, Carrier Testing, Diagnostic Testing, Predictive Testing), By Type (Single Gene Tests, Panel Tests, Whole Exome Sequencing, Whole Genome Sequencing, Non-Invasive Prenatal Testing), By Service Type (Laboratory Services, Diagnostic Services, Consultation Services), By End User (Hospitals, Clinical Laboratories, Research Institutions, Homecare Settings) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast

Genetic Testing Market Overview

As per MRFR analysis, the Genetic Testing Market Size was estimated at 11.62 (USD Billion) in 2023.The Genetic Testing Market Industry is expected to grow from 12.38(USD Billion) in 2024 to 25 (USD Billion) by 2035. The Genetic Testing Market CAGR (growth rate) is expected to be around 6.59% during the forecast period (2025 - 2035).

Key Genetic Testing Market Trends Highlighted

The Global Genetic Testing Market is undergoing substantial growth as a result of the rising prevalence of genetic disorders and the transition to personalized medicine. Advancements in sequencing technologies have facilitated the development of more precise and accessible genetic testing, which are among the primary market drivers. This has resulted in a heightened awareness of the significance of early diagnosis and the genetic health dangers, which in turn has increased the demand for genetic testing services. In addition, the market has been further bolstered by the increasing support of governments and health organizations to integrate genetic testing into standard healthcare practices. As healthcare providers endeavor to incorporate these tests into routine medical care, the genetic testing market is experiencing an expansion of opportunities, which will enhance resource allocation and treatment outcomes. 

Additionally, the utilization of genetic testing for pharmacogenomics has significant potential, as it allows for the development of personalized medication therapies that are based on the genetic profile of the individual. Additionally, the growth of direct-to-consumer genetic testing is appealing to a broad audience, as it fosters public interest in genetics and offers insights into ancestry and health predispositions. Whole-genome sequencing and advancements in non-invasive prenatal testing are among the most recent trends that are gathering momentum on a global scale. The demand for genetic testing services has increased in tandem with the proliferation of telehealth, which enables patients to obtain genetic counseling and testing remotely.

Additionally, a focus on ethical concerns and regulatory frameworks is becoming vital as the market expands, aiming to protect consumer rights and ensure the responsible use of genetic information. These factors collectively shape the landscape of the Global Genetic Testing Market, illustrating its pivotal role in the future of healthcare.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Genetic Testing Market Drivers

Increasing Prevalence of Genetic Disorders

In the Global Genetic Testing Market Industry, the rising prevalence of genetic disorders plays a critical role in market growth. According to the World Health Organization, genetic disorders affect approximately 1 in every 160 live births globally. This alarming statistic represents millions of individuals at risk, prompting governments and health organizations to focus on genetic testing as a feasible solution for early detection and personalized treatments.

For instance, the global increase in congenital disorders has driven initiatives from established organizations like the National Institutes of Health, promoting Research and Development (R) for genetic testing technologies and raising public awareness. Consequently, the demand for genetic testing services and products is expected to rise significantly, positioning it as a cornerstone of modern healthcare and impacting market trends positively.

Advancements in Genetic Testing Technologies

Technological advancements are propelling the Global Genetic Testing Market Industry forward. Innovations such as next-generation sequencing (NGS) and whole-exome sequencing (WES) have drastically reduced costs and improved the accuracy of genetic tests. Research published by the American Society of Human Genetics highlights that the cost of sequencing a human genome has dropped from approximately 100 million USD to less than 1,000 USD in the last decade.

This reduction fosters wider accessibility to genetic testing among different demographic groups, driving the demand for products and services within the industry. As technology continues to evolve, established companies in the market are consistently investing in R, creating a cycle of innovation and market growth.

Growth of Preventive Healthcare Initiatives

The growth of preventive healthcare initiatives further boosts the Global Genetic Testing Market Industry. Governments and healthcare organizations are increasingly advocating for preventive measures to reduce the impact of diseases, leading to a proactive approach in healthcare systems around the world. Data from the Centers for Disease Control and Prevention indicates that preventive healthcare could save the healthcare system over 50 billion USD annually.

This economic impact represents an opportunity for genetic testing to play a crucial role in early disease detection, risk assessment, and personalized medicine. Agencies like the World Health Organization have emphasized the importance of integrating genetic testing into public health strategies, thus reinforcing its role in the healthcare ecosystem and stimulating market growth.

Genetic Testing Market Segment Insights

Genetic Testing Market Application Insights

The Global Genetic Testing Market, particularly in the realm of Application, is manifesting substantial growth, with a total market value projected at 12.38 USD Billion in 2024 and soaring to 25.0 USD Billion by 2035. This segment is characterized by various critical applications, namely Prenatal Testing, Newborn Screening, Carrier Testing, Diagnostic Testing, and Predictive Testing, each contributing significantly to the overall market dynamics. Prenatal Testing is expected to hold a major share, valued at 3.1 USD Billion in 2024 and set to rise to 6.0 USD Billion in 2035, highlighting its essential role in facilitating early detection of genetic disorders in expecting mothers.Similarly, Newborn Screening Testing is valued at 2.8 USD Billion in 2024. It is anticipated to grow to 5.5 USD Billion by 2035, showcasing its critical function in identifying congenital disorders that could impact newborn health. 

Carrier Testing, valued at 2.2 USD Billion in 2024, will see a rise to 4.4 USD Billion by 2035, proving its significance for individuals planning to start a family, as it informs them about potential genetic risks. Diagnostic Testing is another key player, currently valued at 2.78 USD Billion and expected to grow to 5.3 USD Billion, addressing urgent healthcare needs by confirming or denying genetic disorders based on clinical presentations.

Lastly, Predictive Testing, valued at 1.5 USD Billion in 2024, is projected to expand to 3.8 USD Billion by 2035, offering individuals foresight regarding hereditary conditions, which is vital for proactive health management. This market segmentation underscores not only the burgeoning numbers but also the growing awareness and demand for genetic testing as part of public health initiatives globally. By integrating genetic insights into routine healthcare, these applications change the dynamics of preventative care and cultivate opportunities for personalized medicine, robustly positioning the Global Genetic Testing Market for future innovations and growth opportunities.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Genetic Testing Market Type Insights

The Global Genetic Testing Market is experiencing substantial growth, with projections showing a market valuation of 12.38 billion USD in 2024. This market includes various types of genetic testing, reflecting diverse applications in healthcare and research. Among these, Single Gene Tests allow targeted analysis for specific genetic conditions, which is vital for directing treatment decisions. Panel Tests provide a broader view by analyzing multiple genes at once, thus improving diagnostic accuracy for complex disorders. Whole Exome Sequencing targets the coding regions of the genome, uncovering variants linked to diseases. At the same time, Whole Genome Sequencing offers a comprehensive examination of an individual’s entire genetic makeup, presenting the vast potential for personalized medicine.

Additionally, Non-Invasive Prenatal Testing is gaining popularity for its ability to assess fetal genetic conditions with minimal risk to the mother. Collectively, these types play a critical role in advancing precision medicine, promoting preventative care practices, and addressing evolving patient needs within the Global Genetic Testing Market landscape. Ongoing technological advancements and increasing awareness among healthcare providers and patients worldwide further support this segmentation.

Genetic Testing Market Service Type Insights

The Global Genetic Testing Market, valued at 12.38 USD Billion in 2024, is poised for significant expansion, reaching an estimated 25.0 USD Billion by 2035. The market segmentation for Service Type encompasses various offerings, primarily including Laboratory Services, Diagnostic Services, and Consultation Services. Laboratory Services play a crucial role in managing and analyzing genetic material, which aids in accurate disease prognosis. Diagnostic Services are pivotal in identifying genetic disorders and enhancing patient outcomes through precise testing methods.

Meanwhile, Consultation Services provide essential guidance, helping patients navigate the complexities of genetic information and its implications. The growth in this market is fueled by rising demand for personalized medicine, the increasing prevalence of genetic disorders, and the growing awareness of genetic testing benefits. Moreover, advancements in technology and a robust healthcare infrastructure globally contribute to market growth. However, challenges such as ethical considerations and varying regulatory landscapes may impact the market dynamics.Overall, the Global Genetic Testing Market is set to grow steadily, supported by innovations and heightened healthcare focus on genetic insights.

Genetic Testing Market End User Insights

In the Global Genetic Testing Market, the End User segment plays a vital role in driving market dynamics and shaping trends. As of 2024, the market is projected to reach a valuation of 12.38 USD Billion, with a significant portion attributed to Hospitals, which serve as primary facilities for genetic testing due to their advanced infrastructure and expertise. Clinical Laboratories also contribute notably, handling a variety of genetic tests essential for diagnostics and personalized medicine. Research Institutions are critical for advancing genetic research, particularly in areas like genomics and rare diseases, fostering innovation and discovery.

Moreover, Homecare Settings have emerged as an essential aspect, reflecting the shift towards personalized healthcare and patient convenience. The interplay between these End Users showcases the diverse applications of genetic testing, driven by factors such as increasing awareness, technological advancements, and the growing prevalence of genetic disorders. The Global Genetic Testing Market statistics indicate that this segment will continue to grow, highlighting the opportunities for improved healthcare outcomes and personalized approaches to understanding genetic conditions across the globe.

Genetic Testing Market Regional Insights

The Global Genetic Testing Market is segmented regionally into North America, Europe, Asia-Pacific (APAC), South America, and the Middle East and Africa (MEA), with North America holding a significant portion of the market, valued at 5.0 USD Billion in 2024 and expected to grow to 10.1 USD Billion by 2035. The region's prominence is due to advanced healthcare infrastructure and significant investments in research and development. Europe follows suit, with market values starting at 3.2 USD Billion in 2024 and escalating to 6.75 USD Billion in 2035, driven by increasing awareness and government initiatives promoting genetic testing.

APAC also showcases substantial growth potential, beginning at 2.7 USD Billion in 2024 and reaching 5.7 USD Billion in 2035, as countries in the region invest in modern healthcare technologies. Meanwhile, South America and MEA represent smaller yet emerging markets, projected to reach 0.8 USD Billion and 0.68 USD Billion in 2024, expanding to 1.7 USD Billion and 1.75 USD Billion by 2035, respectively. These regions are now starting to leverage genetic testing to enhance healthcare outcomes, thereby signaling significant opportunities for growth in the Global Genetic Testing Market.Overall, regional dynamics reflect varying growth drivers and healthcare investments, leading to diverse opportunities in different parts of the world.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Genetic Testing Market Key Players and Competitive Insights:

The Global Genetic Testing Market has seen substantial evolution in recent years, driven by increasing awareness of genetics and the importance of personalized medicine. The rise in genetic testing demands across various sectors, such as prenatal testing, oncology, and chronic disease management, has cultivated a dynamic competitive landscape. As healthcare providers and patients alike increasingly recognize the value of genetic insights in decision-making processes, numerous companies have emerged to offer innovative solutions catering to this growing need. 

Additionally, advancements in technology and regulatory frameworks are shaping the market, fostering both opportunities and challenges among the key players. Companies are focusing on research and development, strategic partnerships, and acquisitions to enhance their service offerings and increase market share, further driving competition.Abbott Laboratories has established a robust presence in the Global Genetic Testing Market through its commitment to innovation and quality. The company is recognized for its extensive product portfolio that encompasses a range of genetic testing solutions, including non-invasive prenatal tests and assays for hereditary diseases. 

Abbott places a strong emphasis on integrating cutting-edge technology into its testing processes, thus improving accuracy and reliability. The company’s competitive edge lies in its strong research capabilities, partnerships with healthcare providers, and a solid reputation for delivering high-quality diagnostic tools. These attributes enable Abbott Laboratories to maintain a significant foothold in the market while continually adapting to changing customer needs and preferences, positioning itself as a trusted leader in genetic testing.

Myriad Genetics is another key player in the Global Genetic Testing Market, known for its leadership in molecular diagnostics and its focus on hereditary cancer testing. The company offers a specialized range of services, including genetic tests for breast, ovarian, and other cancers, making it a prominent name within oncology. Myriad has cultivated a strong market presence through continuous innovation and the development of proprietary tests that provide valuable insights for treatment decisions. One of the main strengths of Myriad Genetics lies in its ability to leverage strategic partnerships and collaborations to enhance its product offerings, leading to significant growth in recent years. Additionally, the company has actively pursued mergers and acquisitions to strengthen its position and expand into new markets. Its comprehensive approach to genetic testing through research-driven initiatives further solidifies its standing in the global arena, making it a formidable competitor in the industry.

Key Companies in the Genetic Testing Market Include:

• Abbott Laboratories




• Myriad Genetics




• Thermo Fisher Scientific




• Color Genomics




• Exact Sciences




• Hermes Genetic




• Roche




• Veracyte




• Illumina




• Genomic Health




• Qiagen




• 23andMe




• Bristol-Myers Squibb




• Invitae

Genetic Testing Market Industry Developments

The Global Genetic Testing Market has recently witnessed notable developments, including increased demand for genetic testing services driven by advances in precision medicine and personalized healthcare. In October 2023, Myriad Genetics announced the launch of its new correlative testing platform aimed at enhancing patient care in oncology. Additionally, in September 2023, Abbott Laboratories expanded its genetic testing portfolio with new tests for hereditary cancer risk, targeting a growing focus on preventative health measures. In terms of mergers and acquisitions, Invitae acquired ArcherDX in September 2020, a significant move aimed at enhancing its molecular diagnostics capabilities. 

Similarly, 23andMe announced a partnership with GlaxoSmithKline in July 2023, expanding their collaborative efforts in genetic research to develop new therapies.The market has seen a surge in valuation, with companies like Illumina and Thermo Fisher Scientific reporting robust quarterly earnings due to increased adoption of genetic testing technologies across various healthcare settings. Over the last couple of years, the market has observed a shift towards home-based genetic testing services, with Color Genomics leveraging digital platforms to reach consumers more effectively. The growing awareness of genetic diseases and advancements in genomic technologies continue to shape the ongoing transformation in this sector.

Genetic Testing Market Segmentation Insights

Genetic Testing Market Application Outlook

• Prenatal Testing




• Newborn Screening




• Carrier Testing




• Diagnostic Testing




• Predictive Testing

Genetic Testing Market Type Outlook

• Single Gene Tests




• Panel Tests




• Whole Exome Sequencing




• Whole Genome Sequencing




• Non-Invasive Prenatal Testing

Genetic Testing Market Service Type Outlook

• Laboratory Services




• Diagnostic Services




• Consultation Services

Genetic Testing Market End User Outlook

• Hospitals




• Clinical Laboratories




• Research Institutions




• Homecare Settings

Genetic Testing Market Regional Outlook

• North America




• Europe




• South America




• Asia Pacific




• Middle East and Africa

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	11.62(USD Billion)
MARKET SIZE 2024	12.38(USD Billion)
MARKET SIZE 2035	25.0(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	6.59% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Abbott Laboratories, Myriad Genetics, Thermo Fisher Scientific, Color Genomics, Exact Sciences, Hermes Genetic, Roche, Veracyte, Illumina, Genomic Health, Qiagen, 23andMe, BristolMyers Squibb, Invitae
SEGMENTS COVERED	Application, Type, Service Type, End User, Regional
KEY MARKET OPPORTUNITIES	Personalized medicine advancements, Increasing demand for prenatal testing, Rising applications in oncology, Growth of direct-to-consumer testing, Expansion of telehealth services.
KEY MARKET DYNAMICS	Technological advancements, Increasing healthcare expenditure, Growing awareness of genetic disorders, Rise in personalized medicine, Government support and funding
COUNTRIES COVERED	North America, Europe, APAC, South America, MEA